Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to assess bronchodilator efficacy as determined by
FEV1, the effect on dyspnoea as determined by the BDI/TDI, the effect on health status as
determined by the SGRQ and the effect on COPD exacerbations.